Consolidated Statements of Stockholders' Equity (Deficit) - USD ($) $ in Thousands |
Total |
Common Stock [Member] |
Additional Paid-In Capital [Member] |
Treasury Stock [Member] |
Accumulated Deficit [Member] |
Series A Preferred Stock [Member] |
| Beginning Balance at Dec. 31, 2012 |
$ 49,778
|
$ 38
|
$ 143,703
|
$ (47)
|
$ (93,919)
|
$ 3
|
| Beginning Balance, shares at Dec. 31, 2012 |
|
37,497,703
|
|
|
|
2,709,300
|
| Stock-based compensation |
3,327
|
|
3,327
|
|
|
|
| Stock option exercise |
$ 357
|
|
357
|
|
|
|
| Stock option exercise, shares |
115,667
|
115,667
|
|
|
|
|
| Restricted stock awards, shares |
|
80,498
|
|
|
|
|
| Warrant derivative liability reclassified to equity |
$ 11
|
|
11
|
|
|
|
| Warrant exercises |
50
|
|
50
|
|
|
|
| Warrant exercises, shares |
|
10,000
|
|
|
|
|
| Shares issued to Arcion in acquisition of research and development license |
2,073
|
$ 1
|
2,072
|
|
|
|
| Shares issued to Arcion in acquisition of research and development license, shares |
|
500,516
|
|
|
|
|
| Warrants issued in connection with notes payable |
986
|
|
986
|
|
|
|
| Net loss |
(57,394)
|
|
|
|
(57,394)
|
|
| Ending Balance at Dec. 31, 2013 |
(812)
|
$ 39
|
150,506
|
(47)
|
(151,313)
|
$ 3
|
| Ending Balance, shares at Dec. 31, 2013 |
|
38,204,384
|
|
|
|
2,709,300
|
| Stock-based compensation |
6,883
|
|
6,883
|
|
|
|
| Stock option exercise |
$ 4,580
|
$ 1
|
4,579
|
|
|
|
| Stock option exercise, shares |
1,332,563
|
1,332,563
|
|
|
|
|
| Restricted stock awards, shares |
|
473,893
|
|
|
|
|
| Warrant derivative liability reclassified to equity |
$ 17,478
|
|
17,478
|
|
|
|
| Warrant exercises |
7,741
|
$ 2
|
7,739
|
|
|
|
| Warrant exercises, shares |
|
1,999,153
|
|
|
|
|
| Cashless exercise of warrants |
0
|
$ 0
|
0
|
0
|
0
|
$ 0
|
| Cashless exercise of warrants, shares |
|
218,367
|
|
|
|
|
| Shares issued pursuant to registered direct offering, net |
58,182
|
$ 8
|
58,174
|
|
|
|
| Shares issued pursuant to registered direct offering, net shares |
|
7,500,000
|
|
|
|
|
| Shares issued pursuant to an at the market offering, net |
14,480
|
$ 1
|
14,479
|
|
|
|
| Shares issued pursuant to an at the market offering, shares |
|
1,304,410
|
|
|
|
|
| Short swing profit return |
82
|
|
82
|
|
|
|
| Conversion of preferred shares to common shares |
|
$ 1
|
|
|
|
$ (1)
|
| Conversion of preferred shares to common shares, shares |
|
570,300
|
|
|
|
(570,300)
|
| Net loss |
(54,218)
|
|
|
|
(54,218)
|
|
| Ending Balance at Dec. 31, 2014 |
54,396
|
$ 52
|
259,920
|
$ (47)
|
$ (205,531)
|
$ 2
|
| Ending Balance, shares at Dec. 31, 2014 |
|
51,603,070
|
|
|
|
2,139,000
|
| Stock-based compensation |
$ 14,249
|
|
$ 14,249
|
|
|
|
| Stock-based compensation, shares |
0
|
0
|
0
|
0
|
0
|
0
|
| Stock option exercise |
$ 755
|
|
$ 755
|
|
|
|
| Stock option exercise, shares |
235,480
|
223,923
|
|
|
|
|
| Restricted stock awards |
$ 1
|
$ 1
|
|
|
|
|
| Restricted stock awards, shares |
|
857,677
|
|
|
|
|
| Warrant exercises |
1
|
|
1
|
|
|
|
| Warrant exercises, shares |
|
284
|
|
|
|
|
| Short swing profit return |
6
|
|
6
|
|
|
|
| Conversion of preferred shares to common shares, shares |
|
45,845
|
|
|
|
(45,845)
|
| Equity financing costs |
(40)
|
|
(40)
|
|
|
|
| Net loss |
(37,672)
|
|
|
|
$ (37,672)
|
|
| Ending Balance at Dec. 31, 2015 |
$ 31,696
|
$ 53
|
$ 274,891
|
$ (47)
|
$ (243,203)
|
$ 2
|
| Ending Balance, shares at Dec. 31, 2015 |
|
52,730,799
|
|
|
|
2,093,155
|